🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to evaluate how well LY3549492 is tolerated an...
Status
Completed
Location
Hakata Clinic
Start Date
2025-05-07
Trial ID
NCT06869018
Many patients with schizophrenia and schizoaffective disorder have symptoms...
Status
Terminated
Location
NYS Psychiatric Institute
Start Date
2007-10-10
Trial ID
NCT00591318
Treatments Being Tested
The PolarisDMD study is a Phase 3, global study to evaluate the efficacy an...
Status
Completed
Location
Arkansas Children's Hospital
Start Date
2018-10-02
Trial ID
NCT03703882
Treatments Being Tested
Evaluate the safety and effectiveness of OC-01 (varenicline) nasal spray fo...
Status
Completed
Location
Vance Thompson Vision ND
Start Date
2021-10-20
Trial ID
NCT05082974
Treatments Being Tested
This is a multicenter double-blind, placebo-controlled study to evaluate th...
Status
Terminated
Location
University of Alabama
Start Date
2018-08-01
Trial ID
NCT03449524
Treatments Being Tested
The purpose of this study is to evaluate the safety and tolerability of sin...
Status
Terminated
Location
Clinical Trial Site
Start Date
2018-12-05
Trial ID
NCT03767829
FT-4202 is an oral small-molecule agonist of pyruvate kinase red blood cell...
Status
Completed
Location
Woodland International Research Group (SCD subjects only)
Start Date
2018-12-11
Trial ID
NCT03815695
Treatments Being Tested
This multi-center, randomized, double-blind, placebo-controlled, parallel-g...
Status
Completed
Location
Multiple Locations
Start Date
2011-12
Trial ID
NCT01457677
This study aims to identify and compare the effects of acute and chronic ex...
Status
Recruiting
Location
University of Texas at Austin
Start Date
2023-11-27
Trial ID
NCT05972265
Efficacy and safety of early administration of the SGLT-2 inhibitor dapagli...
Status
Completed
Location
National Medical Research Center for Cardiology, Ministry of Health of Russian Federation
Start Date
2022-06-01
Trial ID
NCT05795400
Treatments Being Tested